|
1
|
Morgan E, Arnold M, Gini A, Lorenzoni V,
Cabasag CJ, Laversanne M, Vignat J, Ferlay J, Murphy N and Bray F:
Global burden of colorectal cancer in 2020 and 2040: Incidence and
mortality estimates from GLOBOCAN. Gut. 72:338–344. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
De Rosa M, Pace U, Rega D, Costabile V,
Duraturo F, Izzo P and Delrio P: Genetics, diagnosis and management
of colorectal cancer (Review). Oncol Rep. 34:1087–1096. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Manfredi S, Lepage C, Hatem C, Coatmeur O,
Faivre J and Bouvier AM: Epidemiology and management of liver
metastases from colorectal cancer. Ann Surg. 244:254–259. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu N, Dai Q, Zheng G, He C, Parisien M
and Pan T: N(6)-methyladenosine-dependent RNA structural switches
regulate RNA-protein interactions. Nature. 518:560–564. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang X, Zhao BS, Roundtree IA, Lu Z, Han
D, Ma H, Weng X, Chen K, Shi H and He C: N(6)-methyladenosine
modulates messenger RNA translation efficiency. Cell.
161:1388–1399. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang X, Lu Z, Gomez A, Hon GC, Yue Y, Han
D, Fu Y, Parisien M, Dai Q, Jia G, et al:
N6-methyladenosine-dependent regulation of messenger RNA stability.
Nature. 505:117–120. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Alarcón CR, Lee H, Goodarzi H, Halberg N
and Tavazoie SF: N6-methyladenosine marks primary microRNAs for
processing. Nature. 519:482–485. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang X, Feng J, Xue Y, Guan Z, Zhang D,
Liu Z, Gong Z, Wang Q, Huang J, Tang C, et al: Structural basis of
N(6)-adenosine methylation by the METTL3-METTL14 complex. Nature.
534:575–578. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zeng C and Huang W, Li Y and Huang W:
Roles of METTL3 in cancer: Mechanisms and therapeutic targeting. J
Hematol Oncol. 13:1172020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yue B, Song C, Yang L, Cui R, Cheng X,
Zhang Z and Zhao G: METTL3-mediated N6-methyladenosine modification
is critical for epithelial-mesenchymal transition and metastasis of
gastric cancer. Mol Cancer. 18:1422019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Han J, Wang JZ, Yang X, Yu H, Zhou R, Lu
HC, Yuan WB, Lu JC, Zhou ZJ, Lu Q, et al: METTL3 promote tumor
proliferation of bladder cancer by accelerating pri-miR221/222
maturation in m6A-dependent manner. Mol Cancer. 18:1102019.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li T, Hu PS, Zuo Z, Lin JF, Li X, Wu QN,
Chen ZH, Zeng ZL, Wang F, Zheng J, et al: METTL3 facilitates tumor
progression via an m6A-IGF2BP2-dependent mechanism in
colorectal carcinoma. Mol Cancer. 18:1122019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhu Y, Li B, Liu Z, Jiang L, Wang G, Lv M
and Li D: Up-regulation of lncRNA SNHG1 indicates poor prognosis
and promotes cell proliferation and metastasis of colorectal cancer
by activation of the Wnt/β-catenin signaling pathway. Oncotarget.
8:111715–111727. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Avazpour N, Hajjari M, Kazemi Nezhad SR
and Tahmasebi Birgani M: SNHG1 long noncoding RNA is potentially
up-regulated in colorectal adenocarcinoma. Asian Pac J Cancer Prev.
21:897–901. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Thin KZ, Tu JC and Raveendran S: Long
non-coding SNHG1 in cancer. Clin Chim Acta. 494:38–47. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sun X, Wang Z and Yuan W: Down-regulated
long non-coding RNA SNHG1 inhibits tumor genesis of colorectal
carcinoma. Cancer Biomark. 20:67–73. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bai J, Xu J, Zhao J and Zhang R: lncRNA
SNHG1 cooperated with miR-497/miR-195-5p to modify
epithelial-mesenchymal transition underlying colorectal cancer
exacerbation. J Cell Physiol. 235:1453–1468. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sheffer M, Bacolod MD, Zuk O, Giardina SF,
Pincas H, Barany F, Paty PB, Gerald WL, Notterman DA and Domany E:
Association of survival and disease progression with chromosomal
instability: A genomic exploration of colorectal cancer. Proc Natl
Acad Sci USA. 106:7131–7136. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lin G, He X, Ji H, Shi L, Davis RW and
Zhong S: Reproducibility Probability Score-incorporating
measurement variability across laboratories for gene selection. Nat
Biotechnol. 24:1476–1477. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Barrett T, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, Holko M, et al: NCBI GEO: Archive for functional
genomics data sets-update. Nucleic Acids Res 41(Database issue).
D991–D995. 2013.PubMed/NCBI
|
|
22
|
Chandrashekar DS, Bashel B, Balasubramanya
SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and
Varambally S: UALCAN: A portal for facilitating tumor subgroup gene
expression and survival analyses. Neoplasia. 19:649–658. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xuan JJ, Sun WJ, Lin PH, Zhou KR, Liu S,
Zheng LL, Qu LH and Yang JH: RMBase v2.0: Deciphering the map of
RNA modifications from epitranscriptome sequencing data. Nucleic
Acids Res 46(D1). D327–D334. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Haderk F, Olivas V and Bivona TG:
Immunohistochemistry to study YAP in human tissue samples. Methods
Mol Biol. 1893:89–95. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang Y, Zeng X, Wang N, Zhao W, Zhang X,
Teng S, Zhang Y and Lu Z: Long noncoding RNA DANCR, working as a
competitive endogenous RNA, promotes ROCK1-mediated proliferation
and metastasis via decoying of miR-335-5p and miR-1972 in
osteosarcoma. Mol Cancer. 17:892018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shang A, Gu C, Wang W, Wang X, Sun J, Zeng
B, Chen C, Chang W, Ping Y, Ji P, et al: Exosomal circPACRGL
promotes progression of colorectal cancer via the
miR-142-3p/miR-506-3p-TGF-β1 axis. Mol Cancer. 19:1172020.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zuo X, Chen Z, Gao W, Zhang Y, Wang J,
Wang J, Wang J, Cao M, Cai J, Wu J and Wang X: M6A-mediated
upregulation of LINC00958 increases lipogenesis and acts as a
nanotherapeutic target in hepatocellular carcinoma. J Hematol
Oncol. 13:52020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xue L, Li J, Lin Y, Liu D, Yang Q, Jian J
and Peng J: m6 A transferase METTL3-induced lncRNA
ABHD11-AS1 promotes the Warburg effect of non-small-cell lung
cancer. J Cell Physiol. 236:2649–2658. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jin D, Guo J, Wu Y, Du J, Yang L, Wang X,
Di W, Hu B, An J, Kong L, et al: m6A mRNA methylation
initiated by METTL3 directly promotes YAP translation and increases
YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to
induce NSCLC drug resistance and metastasis. J Hematol Oncol.
12:1352019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang L, Jiang X, Wang Z, Zhong X, Tai S
and Cui Y: Small nucleolar RNA host gene 1: A new biomarker and
therapeutic target for cancers. Pathol Res Pract. 214:1247–1252.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fu Y, Yin Y, Peng S, Yang G, Yu Y, Guo C
and Qin Y, Zhang X, Xu W and Qin Y: Small nucleolar RNA host gene 1
promotes development and progression of colorectal cancer through
negative regulation of miR-137. Mol Carcinog. 58:2104–2117. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Barbieri I and Kouzarides T: Role of RNA
modifications in cancer. Nat Rev Cancer. 20:303–322. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Desrosiers R, Friderici K and Rottman F:
Identification of methylated nucleosides in messenger RNA from
Novikoff hepatoma cells. Proc Natl Acad Sci USA. 71:3971–3975.
1974. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fang Z, Hu Y, Hu J, Huang Y, Zheng S and
Guo C: The crucial roles of N6-methyladenosine
(m6A) modification in the carcinogenesis and progression
of colorectal cancer. Cell Biosci. 11:722021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang C, Meng Y, Zhao J, Ma J, Zhao Y, Gao
R, Liu W and Zhou X: Deubiquitinase USP13 regulates glycolytic
reprogramming and progression in osteosarcoma by stabilizing
METTL3/m6A/ATG5 axis. Int J Biol Sci. 19:2289–2303.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bi X, Lv X, Liu D, Guo H, Yao G, Wang L,
Liang X and Yang Y: METTL3-mediated maturation of miR-126-5p
promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR
pathway. Cancer Gene Ther. 28:335–349. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen XY, Zhang J and Zhu JS: The role of
m6A RNA methylation in human cancer. Mol Cancer.
18:1032019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bokar JA, Rath-Shambaugh ME, Ludwiczak R,
Narayan P and Rottman F: Characterization and partial purification
of mRNA N6-adenosine methyltransferase from HeLa cell nuclei.
Internal mRNA methylation requires a multisubunit complex. J Biol
Chem. 269:17697–17704. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang P, Doxtader KA and Nam Y: Structural
basis for cooperative function of Mettl3 and Mettl14
methyltransferases. Mol Cell. 63:306–317. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Shen C, Xuan B, Yan T, Ma Y, Xu P, Tian X,
Zhang X, Cao Y, Ma D, Zhu X, et al: m6A-dependent
glycolysis enhances colorectal cancer progression. Mol Cancer.
19:722020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang Y, Kang M, Zhang B, Meng F, Song J,
Kaneko H, Shimamoto F and Tang B: m6A
modification-mediated CBX8 induction regulates stemness and
chemosensitivity of colon cancer via upregulation of LGR5. Mol
Cancer. 18:1852019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Peng W, Li J, Chen R, Gu Q, Yang P, Qian
W, Ji D, Wang Q, Zhang Z, Tang J and Sun Y: Upregulated METTL3
promotes metastasis of colorectal Cancer via miR-1246/SPRED2/MAPK
signaling pathway. J Exp Clin Cancer Res. 38:3932019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chen RX, Chen X, Xia LP, Zhang JX, Pan ZZ,
Ma XD, Han K, Chen JW, Judde JG, Deas O, et al:
N6-methyladenosine modification of circNSUN2 facilitates
cytoplasmic export and stabilizes HMGA2 to promote colorectal liver
metastasis. Nat Commun. 10:46952019. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wu Y, Yang X, Chen Z, Tian L, Jiang G,
Chen F, Li J, An P, Lu L, Luo N, et al: m6A-induced
lncRNA RP11 triggers the dissemination of colorectal cancer cells
via upregulation of Zeb1. Mol Cancer. 18:872019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Tycowski KT, Shu MD and Steitz JA:
Requirement for intron-encoded U22 small nucleolar RNA in 18S
ribosomal RNA maturation. Science. 266:1558–1561. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhao Y, Qin ZS, Feng Y, Tang XJ, Zhang T
and Yang L: Long non-coding RNA (lncRNA) small nucleolar RNA host
gene 1 (SNHG1) promote cell proliferation in colorectal cancer by
affecting P53. Eur Rev Med Pharmacol Sci. 22:976–984.
2018.PubMed/NCBI
|
|
48
|
Patil DP, Chen CK, Pickering BF, Chow A,
Jackson C, Guttman M and Jaffrey SR: m(6)A RNA methylation promotes
XIST-mediated transcriptional repression. Nature. 537:369–373.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ni W, Yao S, Zhou Y, Liu Y, Huang P, Zhou
A, Liu J, Che L and Li J: Long noncoding RNA GAS5 inhibits
progression of colorectal cancer by interacting with and triggering
YAP phosphorylation and degradation and is negatively regulated by
the m6A reader YTHDF3. Mol Cancer. 18:1432019.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Warda AS, Kretschmer J, Hackert P, Lenz C,
Urlaub H, Höbartner C, Sloan KE and Bohnsack MT: Human METTL16 is a
N6-methyladenosine (m6A) methyltransferase
that targets pre-mRNAs and various non-coding RNAs. EMBO Rep.
18:2004–2014. 2017. View Article : Google Scholar : PubMed/NCBI
|
